Browse studies, page 104
Page 104 of 1,286, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- Editorial Comment from Dr Chapple to Long‐term safety and efficacy of the novel β3‐adrenoreceptor agonist vibegron in Japanese patients with overactive bladder: A phase III prospective study International journal of urology, 2018
- PD02-05 efficacy and safety of vibegron as adjuvant treatment on refractory neurogenic bladder dysfunction in children with spina bifida Journal of Urology, 2022
- Comparison of solifenacin versus combination of solifenacin and tamsulosin in improving unilateral double-J stent related lower urinary tract symptoms - a prospective randomized control trial 2021
- Clinical and economic value of onabotulinumtoxinA vs oral pharmacotherapies in overactive bladder in the United States Journal of Medical Economics, 2026
- Electroacupuncture Versus Pelvic Floor Muscle Training Plus Solifenacin for Women With Mixed Urinary Incontinence: A Randomized Noninferiority Trial Mayo Clinic proceedings, 2019
- Efficacy and Safety of Vibegron Add-on Therapy in Men with Persistent Storage Symptoms after Receiving Alpha 1-Blocker or Phosphodiesterase 5 Inhibitor: A Preliminary Study Urology, 2021
- Cost-Utility Analysis of Mirabegron Compared to Solifenacin in the Treatment of Overactive Bladder (OAB) in Iran Iranian journal of pharmaceutical research, 2023
- Interpretation of the Meaningfulness of Symptom Reduction with Vibegron in Patients with Overactive Bladder: Analyses from EMPOWUR Advances in Therapy, 2021
- Effect of Improvement in Lower Urinary Tract Symptoms on Sexual Function in Men: Tamsulosin Monotherapy vs. Combination Therapy of Tamsulosin and Solifenacin Korean Journal of Urology, 2014
- "Comparative Analysis of Solifenacin Plus Desmopressin Versus Desmopressin Alone in the Treatment of Primary Mono Symptomatic Nocturnal Enuresis". Journal of Pediatric Surgery, 2023
- Vibegron for the Treatment of Patients with Dry and Wet Overactive Bladder: A Subgroup Analysis from the EMPOWUR Trial International journal of clinical practice, 2022
- Impact of vibegron on quality of life in men with overactive bladder receiving treatment for benign prostatic hyperplasia: patient-reported outcomes from the randomized placebo-controlled COURAGE trial Health and Quality of Life Outcomes, 2026
- Clinically Meaningful Improvements With Vibegron in Men With Overactive Bladder and Benign Prostatic Hyperplasia: A Responder Analysis of the Phase 3 COURAGE Trial Urology, 2025
- Safety and efficacy of vibegron in pediatric patients with treatment-resistant nocturnal enuresis: a multicenter retrospective study Translational Pediatrics, 2025
- The efficacy of alfuzosin and solifenacin combination in BPH patients with overactive bladder and low flowrate Experimental and Сlinical Urology, 2025
- Efficacy and Safety of Mirabegron Compared to Solifenacin in Treatment of Non-neurogenic Overactive Bladder in Children: A Randomized Controlled Trial International Brazilian Journal of Urology, 2025
- Cost Analysis of Mirabegron Versus Solifenacin in Overactive Bladder Syndrome Global Journal of Medical, Pharmaceutical, and Biomedical Update, 2025
- Comparative Efficacy of Tamsulosin and Solifenacin in Managing Double J Stent-Related Symptoms: A Randomized Clinical Study Using the USSQ Tool Journal of Liaquat National Hospital, 2025
- A comparative study of efficacy of tamsulosin monotherapy vs. combined (Solifenacin + tamsulosin) in treatment of ureteric stent related symptoms International Journal of Surgery Science, 2021
- Role of tamsulosin a selective alpha 1a-1d blocker vs. combination therapy of tamsulosin and solifenacin M3 antagonist in DJ stent related morbidity: obstructive and irritative scores International Surgery Journal, 2023
- Combination treatment with vibegron and solifenacin for refractory non‐monosymptomatic enuresis Pediatrics International, 2023
- Monotherapy Of Tamsulosin Vs Monotherapy of Solifenacin in The Treatment Of Ureter Stent Discomforts In Urology Patients: A Retrospective Study Journal of Population Therapeutics and Clinical Pharmacology, 2023
- Prospective, Randomized, Multicenter Trial of Peroneal Electrical Transcutaneous Neuromodulation vs Solifenacin in Treatment-naïve Patients With Overactive Bladder Journal of Urology, 2022
- Systematic review and meta-analysis of the efficacy and safety of vibegron vs antimuscarinic monotherapy for overactive bladder Medicine, 2021
- Bars to Justice: The Impact of Rape Myths on Women in Prison bepress Legal Repository, 2016
- Highlights of the University of Toronto Urology Update 2014 Canadian Urological Association Journal, 2015
- Peer Review Report For: The efficacy of adjunctive alpha-blockers on ureteroscopy procedure for ureteral stones: a systematic review and meta-analysis [version 1; peer review: 1 approved, 1 approved with reservations] 2021
- The efficacy of adjunctive alpha-blockers on ureteroscopy procedure for ureteral stones: a systematic review and meta-analysis F1000Research, 2021
- Alfuzosin vs. Silodosin in the Improvement of Ureteral Stent-Related Symptoms after Endoscopic Surgical Treatment of Urolithiasis: A Retrospective Comparison Stem Cell Research International, 2023
- Perbandingan efek agonis reseptor adrenergik β3 DAN antagonis reseptor adrenergik α1 terhadap derajat inflamasi mukosa kandung kemih pada pasien dengan pemasangan stent ureter Hasanuddin University Repository, 2023
- Use of Drugs to Reduce the Morbidity of Ureteral Stents Springer eBooks, 2022
- Ureteral Stent‐Related Symptoms and Pharmacotherapy: A Brief Narrative Review The Journal of Clinical Pharmacology, 2023
- Efficacy and safety of combination of mirabegron and solifenacin in patients with double-J stent related overactive bladder: a prospective study Scientific Reports, 2022
- Comparing efficacy and safety of mirabegron, tamsulosin, and solifenacin in ureteral stent-related symptoms: outcomes from a network meta-analysis Translational Andrology and Urology, 2024
- Double-J stent-related lower urinary tract symptoms: a prospective randomized trial of mirabegron, solifenacin, tamsulosin, and tadalafil and their combinations Gazzetta Medica Italiana Archivio per le Scienze Mediche, 2023
- BRIDGE – Biological Antimicrobial Resistance Inference via Domain-Knowledge Graph Embeddings bioRxiv (Cold Spring Harbor Laboratory), 2026
- Role of parC Mutations at Position 84 on High-Level Delafloxacin Resistance in Methicillin-Resistant Staphylococcus aureus Antibiotics, 2024
- Enhanced Quinolone Resistance and Differential Expression of Efflux Pump nor Genes in Staphylococcus aureus Grown in Platelet Concentrates Antibiotics, 2025
- Atypical detection of group B Streptococcus ST - 17 clone from a diabetic patient with necrotising fasciitis: A case report IDCases, 2026
- Combating antibiotic resistance: mechanisms, challenges, and innovative approaches in antibacterial drug development Exploration of Drug Science, 2025
- Toward better cures for Mycobacterium abscessus lung disease Clinical Microbiology Reviews, 2024
- Advanced Vaginal Nanodelivery of Losartan Potassium via PEGylated Zein Nanoparticles for Methicillin-Resistant Staphylococcus aureus Pharmaceutics, 2025
- Antimicrobial resistance of Clostridioides difficile in veterinary medicine around the world: A scoping review of minimum inhibitory concentrations One Health, 2024
- Implementation of green-assessed nanotechnology and quality by design approach for development of optical sensor for determination of tobramycin in ophthalmic formulations and spiked human plasma BMC Chemistry, 2024
- In-vitro quality assessment of commercially available ciprofloxacin tablets marketed in Arba Minch City, Ethiopia OMO International Journal of Sciences, 2025
- When metagenomic next-generation sequencing detects Nocardia: from clinical interpretation to immune-based clinical management Frontiers in Cellular and Infection Microbiology, 2026
- Rare emm6.10 Streptococcus pyogenes Causing an Unusual Invasive Infection in a Child: Clinical and Genomic Insights Microorganisms, 2025
- The Distribution of Methicillin‐Resistant Staphylococcus aureus and Carbapenem‐Resistant Pseudomonas aeruginosa in the Academic Complex Central Hospital in KwaZulu‐Natal, South Africa: A 5‐Year Retrospective Study From 2019 to 2023 International Journal of Microbiology, 2025
- Karakteristik Klinis dan Profil Terapi Pasien Rawat Inap COVID-19 di Rumah Sakit Akademik Universitas Gadjah Mada Yogyakarta Periode Maret – Agustus 2020 Majalah Farmaseutik, 2024
- Assessing the Genomic Landscape of Salmonella enterica Isolated From Cattle Faeces on a Nigerian Farm MicrobiologyOpen, 2025
- Rationally designed ruthenium(II) complexes combat drug resistance in Staphylococcus aureus via type IIA topoisomerase inhibition ChemRxiv, 2026
- Whole-genome sequencing of clinical isolates of Citrobacter Europaeus in China carrying blaOXA−48 and blaNDM−1 Annals of Clinical Microbiology and Antimicrobials, 2024
- Upregulation of pmrA, pmrB, pmrC, phoQ, phoP, and arnT genes contributing to resistance to colistin in superbug Klebsiella pneumoniae isolates from human clinical samples in Tehran, Iran New Microbes and New Infections, 2024
- Antimicrobial resistance and molecular epidemiology of Streptococcus pneumoniae in China: a 14‑year serial surveillance study across age groups Journal of Infection and Public Health, 2026
- Identification of Antibiotic Drugs against SARS-CoV2 Mpro: A Computational Approach for Drug Repurposing International Journal of Bioinformatics and Intelligent Computing, 2024
- Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing Clinical Microbiology Reviews, 2024
- COVID-19: A Local Report on Patients in the Covid Ward in Bytom, Poland Letters in Applied NanoBioScience, 2026
- Innovative Approaches to Suppressing Pseudomonas aeruginosa Growth and Virulence: Current Status and Future Directions Cellular Microbiology, 2024
- Cardiotoxic Drugs Used in the Treatment of COVID-19 Antibiot Khimioter = Antibiotics and Chemotherapy, 2024
- Dynamic category-sensitive hypergraph inferring and homo-heterogeneous neighbor feature learning for drug-related microbe prediction Bioinformatics, 2024
- Surveillance of antimicrobial resistant pathogens in Canadian retail meat using a One-Health lens: linkages to the human sector through the farm-to-fork continuum Mspace (University of Manitoba), 2025
- Comprehensive Proteomic and Metabolomic Analysis of Novel Substituted Fluoroquinolone Derivatives in Escherichia coli Isolates Biomedical Chromatography, 2026
- Natural products as efflux pump inhibitors enhancing the antibacterial efficacy of quinolones Indian journal of veterinary and animal sciences research., 2025
- Unlocking the Gates: A Novel Diagnostic Molecule for Quantifying Efflux Levels in Gram‐Positive Bacteria Advanced Healthcare Materials, 2025
- Molecular insights into efflux pump genes in ciprofloxacin- and methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis clinical isolates from Iraq Scientific Reports, 2026
- Reversible Evolution of Ceftazidime-Avibactam Resistance Driven by blaKPC-71 and Aerobactin Loss in ST11-KL64 Hypervirulent Klebsiella Pneumoniae Infection and Drug Resistance, 2025
- Mycobacterium appelbergii sp. nov., a Novel Species Isolated from a Drinking Water Fountain in a Rural Community Microorganisms, 2025
- Antibiotic Stewardship Program in a General Hospital in Abu Dhabi, UAE: Preparedness for the COVID-19 Pandemic Cureus, 2024
- Treatment of persistent focalized Q fever: time has come for an international randomized controlled trial Journal of Antimicrobial Chemotherapy, 2024
- Trends of ciprofloxacin use in Kazakhstan, impacts of COVID-19, and strategies for AMR control Scientific Reports, 2025
- Comparative analysis of the physicochemical properties, spectrum of activity, and efficacy of antibacterial agents Repository of the University of Ljubljana (University of Ljubljana), 2026
- Repositioning of Antibiotics in the Treatment of Viral Infections Current Microbiology, 2024
- Establishing Sitafloxacin Epidemiological Cut-off Values (ECOFFs) for Clinical Bacterial Isolates Infection and Drug Resistance, 2025
- Proteome-Wide Reverse Vaccinology and Immunoinformatics-Guided Design of a Multi-Epitope Vaccine Against Legionella pneumophila International Journal of Molecular Sciences, 2026
- Exploring corrosion behavior, antimicrobial evaluation, molecular docking and DFT calculation of thiosemicarbazone ligand and its metal complexes Scientific Reports, 2025
- Genomic Characterization and Antimicrobial Resistance Profile of Streptococcus uberis Strains Isolated from Cows with Mastitis from Northwestern Spain Antibiotics, 2025
- Clostridioides difficile in Honduras: a genomic and phenotypic characterization of the persistent RT027 and emergent RT002 genotypes Journal of Hospital Infection, 2025
- Pharmacological and Therapeutic Features of COVID - 19 Infection in Hodeidah, Yemen Journal of Advances in Medical and Pharmaceutical Sciences, 2024
- Design, synthesis and characterization of 8-[(1H-benzo[d]imidazol-2-yl)methoxy] quinoline derivatives as antimicrobial agents Discover Chemistry., 2025
- Design, Synthesis and In vitro Antitubercular Effect of New Chalcone Derivatives Coupled with 1,2,3‐Triazoles: A Computational Docking Techniques Chemistry & Biodiversity, 2024
- Phytochemical analysis and antibacterial activity of raspberry (Rubus idaeus) fruit extract against Gram-negative multi-drug resistant bacteria from clinical isolates Chemical Bulletin of Kazakh National University, 2025
- Structural and topological analysis of thiosemicarbazone-based metal complexes: computational and experimental study of bacterial biofilm inhibition and antioxidant activity BMC Chemistry, 2025
- Enhanced compound selection using holistic virtual screening for gatifloxacin analogues to overcome dysglycemic effects International Journal of Biology and Chemistry, 2024
- Development of Benzo[b]thiophene Linked-Oxadiazole Derivatives for Potential Antimicrobial and Anti-TB Targets: Evaluation of ADME-Tox and In-silico Docking Journal of Advanced Chemical Sciences, 2026
- Effect of Macrolide and Non-Macrolide Therapy on QTc Interval Prolongation in Cardiac Patients with Community-Acquired Pneumonia Ukrainian journal of cardiovascular surgery, 2025
- In vitro selection and characterization of resistance to pristinamycin in Mycoplasma genitalium Antimicrobial Agents and Chemotherapy, 2026
- Effects of nemonoxacin monotherapy and nemonoxacin combined with minocycline on the prognosis in patients with non-severe Chlamydia psittaci pneumonia Precision medication., 2026
- Insights into the diagnostic and prognostic value of paraoxonase 1-related variables and inflammatory markers in community-acquired pneumonia Chemico-Biological Interactions, 2025
- Serum procalcitonin as a predictor of severity of pneumonia in under-five children: A prospective observational study World Journal of Methodology, 2026
- Not-so-walking pneumonia: challenges in managing mycoplasma complicated by autoimmune hemolytic anemia in a young female International Journal of Research in Medical Sciences, 2024
- Effectiveness of Ceftazidime-Avibactam in Gram-Negative Nosocomial Pneumonia: A Real-World Study in India Cureus, 2024
- Clinical characteristics of Chlamydia psittaci pneumonia and predictors analysis of severe patients: a retrospective observational study Frontiers in Medicine, 2025
- Immunocompetent Patient Co-Infected with COVID-19 and Non-HIV Severe Pneumocystis jirovecii Pneumonia Emerging infectious diseases, 2024
- Mycobacterium goodii pulmonary disease with organizing pneumonia: A case report and review of literature Respirology Case Reports, 2025
- A case of explosive community-acquired pneumonia and septic shock caused by Acinetobacter pittii BMC Pulmonary Medicine, 2025
- An Atypical Pneumonia Case of Quinolone-Refractory Chlamydia Pneumoniae Successfully Treated With Omadacycline Infection and Drug Resistance, 2025
- Mechanism of action of antibacterial drugs in community-acquired pneumonia in young children Современная наука и исследования, 2024
- A Revolutionary Leap: Bridging The Gap in Antibiotic Resistance Against Pneumonia International Journal of Pharmaceutical and Healthcare Innovation., 2026
- The use of fluoroquinolones in the treatment of community-acquired pneumonia and their cardiotoxic effects Clinical Microbiology and Antimicrobial Chemotherapy, 2024
- Novelties in the treatment of community-acquired and hospital-acquired pneumonia Barcelona Respiratory Network, 2025
